Comparison - ASND - NASDAQ

Weiss Ratings	ASND - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Rating	D
Reward Index	Very Weak
Risk Index	Weak
Risk Grade	D
Reward Grade	E

Rating Factors	ASND - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Dividend Index	--
Growth Index	Good
Efficiency Index	Very Weak
Solvency Index	Weak
Total Return Index	Fair
Volatility Index	Weak

Beta / Standard Deviation	ASND - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Beta	0.90

Price History	ASND - NASDAQ	Click to Compare	Click to Compare	Click to Compare
7-Day Total Return	14.59%
30-Day Total Return	33.50%
60-Day Total Return	19.03%
90-Day Total Return	32.78%
Year to Date Total Return	21.01%
1-Year Total Return	13.56%
2-Year Total Return	52.09%
3-Year Total Return	42.20%
5-Year Total Return	69.72%
52-Week High % Change	-0.31%
52-Week Low % Change	51.98%

Price	ASND - NASDAQ	Click to Compare	Click to Compare	Click to Compare
52-Week High Price	$169.37
52-Week Low Price	$111.09
52-Week Low Price (Date)	Sep 12, 2024
52-Week High Price (Date)	Mar 17, 2025

Valuation	ASND - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Market Cap	10.10B
Enterprise Value	10.41B
Price/Earnings (TTM)	--
Earnings Per Share (TTM)	-7.14
Earnings Per Share Growth	-22.97%
Price/Earnings To Growth	--
Price/Sales (TTM)	25.76
Price/Book (Q)	-92.33
Enterprise Value/Revenue (TTM)	26.57
Price	$167.00
Enterprise Value/EBITDA (TTM)	-36.27
Enterprise Value/EBIT	-34.39
Market Cap Category	Large Cap

Dividends and Shares	ASND - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Shares Outstanding	59.79M
Dividend Yield	--
Div. Per Share (Most Recent)	--
Dividend Per Share (TTM)	--
Payout Ratio (TTM)	--
Dividend Per Share (Most Recent)	--

Company Info	ASND - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Phone Number	45 70 22 22 44
Address	--
Website	ascendispharma.com
Country	Denmark
Year Founded	2006

Profitability	ASND - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Operating Margin (TTM)	-77.26%
Profit Margin	-104.65%

Management Effectiveness	ASND - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Return on Assets	-17.74%
Return on Equity	--

Income Statement	ASND - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Revenue (TTM)	391.82M
Total Revenue (TTM)	391.82M
Revenue Per Share	$6.55
Gross Profit (TTM)	344.00M
EBITDA (TTM)	-287.02M
EBIT (TTM)	-302.73M
Net Income (TTM)	-410.04M
Net Income Avl. to Common (TTM)	-410.04M
Total Revenue Growth (Q YOY)	25.05%
Earnings Growth (Q YOY)	56.16%
EPS Diluted (TTM)	-7.14
EPS Diluted Growth (Q YOY)	58.52%

Balance Sheet	ASND - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Cash and Short-Term Inv. (Q)	579.30M
Cash Per Share (Q)	$9.69
Total Current Assets (Q)	1.10B
Total Preferred Equity (Q)	--
Total Equity (Q)	-109.44M
Current Ratio (Q)	1.169
Book Value Per Share (Q)	-$1.83
Total Assets (Q)	1.22B
Total Current Liabilities (Q)	939.91M
Total Debt (Q)	886.86M
Total Liabilities (Q)	1.33B
Total Common Equity (Q)	-109.44M

Cash Flow	ASND - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Cash from Investing (TTM)	7.46M
Cash from Financing (TTM)	487.84M
Net Change in Cash (TTM)	188.63M
Levered Free Cash Flow (TTM)	-108.32M
Cash from Operations (TTM)	-330.90M